Several ways that one can view this recent deal...
Post# of 405
(Total Views: 613)
Posted On: 01/01/2019 11:02:42 PM
Several ways that one can view this recent deal...here is the way I see it FWIW:
INNV gets $3.17M actually closer to $2.8M (after fees) from 1 institutional investor.
They also can get up to $6.79M if all warrants were exercised. The avrg exercise price across the 2 warrant tranches is .075
Now a SINGLE institutional Investor just received 45.3M common shares at a cost of 7 cents which is MORE than Damaj and his Board collectively own. The investor also receive warrants to purchase up to another 90.6M shares of INNV at an avrg of .075 which means they would pay an add'l $6.79M for exercising ALL. The total outlay could very well amount to $9.96M.
- Best guesstimate of current o/s is around 266M which includes this deal, so a reverse split would likely happen sometime rather soon. Right now there are 52M RESTRICTED shares so FLOAT is only ~ 214M (+,- 3M)
To break it down further, the new investor now owns approx.17% of the entire company and many believe this could be a precursor to BIG news / potential buyout down the line. Some are even speculating that it could be a CBD oil player that really wants the use of their BH Platform ???
So, the question is WHY did Damaj agree to make this deal which makes the investor the single largest shareholder? Was it desperation ? Was it insurance to become Profitable after Q1 2019 ?
Interesting times as a reverse is likely but who knows when? a/s is 292.5M so there are approx. 24-26.5M shares left before they hit that. What does the institutional Investor see...as INNV used HC Wainwright
In terms of INNV's cash situation:
2.8M now
6.79M potential from warrants (half within 18 months of a reverse)
~3M from a 15 cent warrant tranche that doesn't expire for about 3 years
* Expecting annual Revenue of around $24M for 2018 and not quite Profitable
INNV gets $3.17M actually closer to $2.8M (after fees) from 1 institutional investor.
They also can get up to $6.79M if all warrants were exercised. The avrg exercise price across the 2 warrant tranches is .075
Now a SINGLE institutional Investor just received 45.3M common shares at a cost of 7 cents which is MORE than Damaj and his Board collectively own. The investor also receive warrants to purchase up to another 90.6M shares of INNV at an avrg of .075 which means they would pay an add'l $6.79M for exercising ALL. The total outlay could very well amount to $9.96M.
- Best guesstimate of current o/s is around 266M which includes this deal, so a reverse split would likely happen sometime rather soon. Right now there are 52M RESTRICTED shares so FLOAT is only ~ 214M (+,- 3M)
To break it down further, the new investor now owns approx.17% of the entire company and many believe this could be a precursor to BIG news / potential buyout down the line. Some are even speculating that it could be a CBD oil player that really wants the use of their BH Platform ???
So, the question is WHY did Damaj agree to make this deal which makes the investor the single largest shareholder? Was it desperation ? Was it insurance to become Profitable after Q1 2019 ?
Interesting times as a reverse is likely but who knows when? a/s is 292.5M so there are approx. 24-26.5M shares left before they hit that. What does the institutional Investor see...as INNV used HC Wainwright
In terms of INNV's cash situation:
2.8M now
6.79M potential from warrants (half within 18 months of a reverse)
~3M from a 15 cent warrant tranche that doesn't expire for about 3 years
* Expecting annual Revenue of around $24M for 2018 and not quite Profitable
(1)
(0)Innovus Pharmaceuticals Inc. (INNV) Stock Research Links
Scroll down for more posts ▼